HIV Stocks List

Related ETFs - A few ETFs which own one or more of the above listed HIV stocks.

Symbol Grade Name Weight
VXF C Vanguard Extended Market ETF 0.0


Compare ETFs

      HIV Stocks Recent News

      Date Stock Title
      Jul 3 GSK GSk snaps six straight days of losses
      Jul 3 GSK GSK Buys Full Rights To Investigational Covid-19 And Influenza Vaccines From CureVac For Around $1.5B
      Jul 3 GSK GSK to Buy CureVac’s Covid-19, Flu Vaccine Rights for Up to $1.56 Billion
      Jul 3 GILD 5 FDA decisions to watch in the third quarter
      Jul 3 GSK Trending tickers: SoftBank, Reddit, Vodafone, GSK
      Jul 3 GSK 3 No-Brainer Stocks to Buy With $300 Right Now for the Second Half of 2024
      Jul 3 GSK CureVac to cut 30% of workforce as GSK buys rights to make flu, covid shots
      Jul 2 RPRX Is Royalty Pharma plc (RPRX) a Good Stock to Buy Now?
      Jul 2 GOVX (GOVX) - Analyzing Geovax Labs's Short Interest
      Jul 2 LH Is It the Right Time to Hold Labcorp (LH) in Your Portfolio?
      Jul 2 GILD Should You Be Concerned About Gilead Sciences, Inc.'s (NASDAQ:GILD) ROE?
      Jul 2 GILD Insider Sale: Chief Medical Officer Merdad Parsey Sells Shares of Gilead Sciences Inc (GILD)
      Jul 1 GSK Bird Flu Shot Hopes Dim as Tracing Woes Undercut Covid Lessons
      Jul 1 GILD Gilead Benefit Helps Employees Navigate Cancer Care
      Jul 1 LH Labcorp to Announce Second Quarter Financial Results on August 1, 2024
      Jul 1 GILD Should You Hold Gilead Sciences (GILD)?
      Jul 1 GILD 3 Magnificent Stocks Retirees Can Buy and Hold Forever
      Jun 27 GSK GSK plc (GSK): Did This Healthcare Stock Show a Strong Performance in Q1?
      Jun 27 GSK GSK stock falls as CDC shifts RSV vaccine recommendation
      Jun 27 GOVX GeoVax Partners with Allucent to Conduct Phase 2b Clinical Study of Next-Generation COVID-19 Vaccine Candidate with Funding from BARDA
      HIV

      The human immunodeficiency virus (HIV) is a lentivirus (a subgroup of retrovirus) that causes HIV infection and over time acquired immunodeficiency syndrome (AIDS). AIDS is a condition in humans in which progressive failure of the immune system allows life-threatening opportunistic infections and cancers to thrive. Without treatment, average survival time after infection with HIV is estimated to be 9 to 11 years, depending on the HIV subtype. In most cases, HIV is a sexually transmitted infection and occurs by contact with or transfer of blood, pre-ejaculate, semen, and vaginal fluids. Non-sexual transmission can occur from an infected mother to her infant during pregnancy, during childbirth by exposure to her blood or vaginal fluid, and through breast milk. Within these bodily fluids, HIV is present as both free virus particles and virus within infected immune cells.
      HIV infects vital cells in the human immune system, such as helper T cells (specifically CD4+ T cells), macrophages, and dendritic cells. HIV infection leads to low levels of CD4+ T cells through a number of mechanisms, including pyroptosis of abortively infected T cells, apoptosis of uninfected bystander cells, direct viral killing of infected cells, and killing of infected CD4+ T cells by CD8+ cytotoxic lymphocytes that recognize infected cells. When CD4+ T cell numbers decline below a critical level, cell-mediated immunity is lost, and the body becomes progressively more susceptible to opportunistic infections, leading to the development of AIDS.

      Browse All Tags